SORTIS INVEST ADVISED THE SHAREHOLDERS OF MEDICAL CENTER HERA IN THE SALE OF THE COMPANY TO FUTUREMEDS – A LANDMARK DEAL FOR THE BULGARIAN CLINICAL RESEARCH SECTOR
SORTIS Invest is pleased to announce its role as the exclusive financial advisor to the shareholders of Medical Center Hera EOOD and Medical Center Hera – Kyustendil EOOD (together “Hera Clinics” or “Hera”) in the sale of the companies to FutureMeds, a European network of dedicated clinical research sites backed by Phoenix Equity Partners. The […]
>> SORTIS INVEST ADVISED THE SHAREHOLDERS OF MEDICAL CENTER HERA IN THE SALE OF THE COMPANY TO FUTUREMEDS – A LANDMARK DEAL FOR THE BULGARIAN CLINICAL RESEARCH SECTOR